This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Subscribe To Our Newsletter & Stay Updated